Focused inspections of cough syrup manufacturing units to commence

The Drugs Controller General of India reportedly announced coordinated inspections of cough syrup manufacturing units by central and state drug authorities. Non-compliant facilities may face stringent action, including licence cancellation. The regulator also plans response timelines for corrective-action notices, with manufacturing licence suspension for delays.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.